190 related articles for article (PubMed ID: 21358282)
1. Measuring cooperative Rev protein-protein interactions on Rev responsive RNA by fluorescence resonance energy transfer.
Vercruysse T; Pawar S; De Borggraeve W; Pardon E; Pavlakis GN; Pannecouque C; Steyaert J; Balzarini J; Daelemans D
RNA Biol; 2011; 8(2):316-24. PubMed ID: 21358282
[TBL] [Abstract][Full Text] [Related]
2. Interaction of the human immunodeficiency virus type 1 Rev protein with a structured region in env mRNA is dependent on multimer formation mediated through a basic stretch of amino acids.
Olsen HS; Cochrane AW; Dillon PJ; Nalin CM; Rosen CA
Genes Dev; 1990 Aug; 4(8):1357-64. PubMed ID: 2227413
[TBL] [Abstract][Full Text] [Related]
3. Formation of trans-activation competent HIV-1 Rev:RRE complexes requires the recruitment of multiple protein activation domains.
Hoffmann D; Schwarck D; Banning C; Brenner M; Mariyanna L; Krepstakies M; Schindler M; Millar DP; Hauber J
PLoS One; 2012; 7(6):e38305. PubMed ID: 22675540
[TBL] [Abstract][Full Text] [Related]
4. Evolution of the HIV-1 Rev Response Element during Natural Infection Reveals Nucleotide Changes That Correlate with Altered Structure and Increased Activity over Time.
Sherpa C; Jackson PEH; Gray LR; Anastos K; Le Grice SFJ; Hammarskjold ML; Rekosh D
J Virol; 2019 Jun; 93(11):. PubMed ID: 30867301
[TBL] [Abstract][Full Text] [Related]
5. Exchange of the basic domain of human immunodeficiency virus type 1 Rev for a polyarginine stretch expands the RNA binding specificity, and a minimal arginine cluster is required for optimal RRE RNA binding affinity, nuclear accumulation, and trans-activation.
Nam YS; Petrovic A; Jeong KS; Venkatesan S
J Virol; 2001 Mar; 75(6):2957-71. PubMed ID: 11222721
[TBL] [Abstract][Full Text] [Related]
6. Puralpha as a cellular co-factor of Rev/RRE-mediated expression of HIV-1 intron-containing mRNA.
Kaminski R; Darbinian N; Sawaya BE; Slonina D; Amini S; Johnson EM; Rappaport J; Khalili K; Darbinyan A
J Cell Biochem; 2008 Mar; 103(4):1231-45. PubMed ID: 17722108
[TBL] [Abstract][Full Text] [Related]
7. Structural model for the cooperative assembly of HIV-1 Rev multimers on the RRE as deduced from analysis of assembly-defective mutants.
Jain C; Belasco JG
Mol Cell; 2001 Mar; 7(3):603-14. PubMed ID: 11463385
[TBL] [Abstract][Full Text] [Related]
8. A DEAD-box protein acts through RNA to promote HIV-1 Rev-RRE assembly.
Lamichhane R; Hammond JA; Pauszek RF; Anderson RM; Pedron I; van der Schans E; Williamson JR; Millar DP
Nucleic Acids Res; 2017 May; 45(8):4632-4641. PubMed ID: 28379444
[TBL] [Abstract][Full Text] [Related]
9. Mechanism of neomycin and Rev peptide binding to the Rev responsive element of HIV-1 as determined by fluorescence and NMR spectroscopy.
Lacourciere KA; Stivers JT; Marino JP
Biochemistry; 2000 May; 39(19):5630-41. PubMed ID: 10801313
[TBL] [Abstract][Full Text] [Related]
10. Nuclear Factor 90, a cellular dsRNA binding protein inhibits the HIV Rev-export function.
Urcuqui-Inchima S; Castaño ME; Hernandez-Verdun D; St-Laurent G; Kumar A
Retrovirology; 2006 Nov; 3():83. PubMed ID: 17125513
[TBL] [Abstract][Full Text] [Related]
11. Perturbation of the carboxy terminus of HIV-1 Rev affects multimerization on the Rev responsive element.
Daly TJ; Rennert P; Lynch P; Barry JK; Dundas M; Rusche JR; Doten RC; Auer M; Farrington GK
Biochemistry; 1993 Aug; 32(34):8945-54. PubMed ID: 8364040
[TBL] [Abstract][Full Text] [Related]
12. Allosteric inhibition of the HIV-1 Rev/RRE interaction by a 3'-methylphosphonate modified antisense oligo-2'-O-methylribonucleotide.
Prater CE; Saleh AD; Wear MP; Miller PS
Oligonucleotides; 2007; 17(3):275-90. PubMed ID: 17854268
[TBL] [Abstract][Full Text] [Related]
13. In vivo HIV-1 Rev multimerization in the nucleolus and cytoplasm identified by fluorescence resonance energy transfer.
Daelemans D; Costes SV; Cho EH; Erwin-Cohen RA; Lockett S; Pavlakis GN
J Biol Chem; 2004 Nov; 279(48):50167-75. PubMed ID: 15294891
[TBL] [Abstract][Full Text] [Related]
14. The human immunodeficiency virus type 1 Rev protein and the Rev-responsive element counteract the effect of an inhibitory 5' splice site in a 3' untranslated region.
Barksdale SK; Baker CC
Mol Cell Biol; 1995 Jun; 15(6):2962-71. PubMed ID: 7760794
[TBL] [Abstract][Full Text] [Related]
15. Synergistic stimulation of HIV-1 rev-dependent export of unspliced mRNA to the cytoplasm by hnRNP A1.
Najera I; Krieg M; Karn J
J Mol Biol; 1999 Feb; 285(5):1951-64. PubMed ID: 9925777
[TBL] [Abstract][Full Text] [Related]
16. Real-time kinetics of HIV-1 Rev-Rev response element interactions. Definition of minimal binding sites on RNA and protein and stoichiometric analysis.
Van Ryk DI; Venkatesan S
J Biol Chem; 1999 Jun; 274(25):17452-63. PubMed ID: 10364175
[TBL] [Abstract][Full Text] [Related]
17. Arginine side-chain dynamics in the HIV-1 rev-RRE complex.
Wilkinson TA; Botuyan MV; Kaplan BE; Rossi JJ; Chen Y
J Mol Biol; 2000 Nov; 303(4):515-29. PubMed ID: 11054288
[TBL] [Abstract][Full Text] [Related]
18. Thermodynamics of Rev-RNA interactions in HIV-1 Rev-RRE assembly.
Jayaraman B; Mavor D; Gross JD; Frankel AD
Biochemistry; 2015 Oct; 54(42):6545-54. PubMed ID: 26422686
[TBL] [Abstract][Full Text] [Related]
19. Proflavine acts as a Rev inhibitor by targeting the high-affinity Rev binding site of the Rev responsive element of HIV-1.
DeJong ES; Chang CE; Gilson MK; Marino JP
Biochemistry; 2003 Jul; 42(26):8035-46. PubMed ID: 12834355
[TBL] [Abstract][Full Text] [Related]
20. An alpha-helical peptidomimetic inhibitor of the HIV-1 Rev-RRE interaction.
Mills NL; Daugherty MD; Frankel AD; Guy RK
J Am Chem Soc; 2006 Mar; 128(11):3496-7. PubMed ID: 16536504
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
